Loading chat...
CO HB1325
Bill
Status
Introduced
3/6/2026
Primary Sponsor
Jarvis Caldwell
Click for details
AI Summary
- Establishes an ibogaine research pilot program within the Behavioral Health Administration (BHA) to study the safety and effectiveness of ibogaine for treating mental health conditions and substance use disorders, with up to 5 authorized pilot sites
- Creates the Ibogaine Research Pilot Program Cash Fund to administer the program and award grants to pilot sites, funded through gifts, grants, and donations
- Expands the definition of "natural medicine" to include semi-synthetic ibogaine derived from tabernanthe iboga or voacanga africana plants, and authorizes the state licensing authority to adopt rules for ibogaine administration, manufacturing, and medical monitoring requirements
- Provides liability protections for facilitators of natural medicine services and physicians administering ibogaine in the pilot program, except in cases of intentional misconduct, gross negligence, or deviation from standard of care
- Requires licensees working with ibogaine to establish benefit-sharing plans for indigenous communities that have traditionally used iboga, and restructures the Natural Medicine Advisory Board's 15 voting member expertise requirements
Legislative Description
Natural Medicine
Liquor, Tobacco, & Marijuana
Last Action
Introduced In House - Assigned to Health & Human Services
3/6/2026
Committee Referrals
Health and Human Services3/6/2026
Full Bill Text
No bill text available